Alda 1
(Synonyms: N-(1,3-苯并二氧杂环戊烯-5-基甲基)-2,6-二氯苯甲酰胺) 目录号 : GC16597
Alda 1是一种醛脱氢酶2（ALDH2）激活剂。
Cas No.:349438-38-6
Sample solution is provided at 25 µL, 10mM.
Alda 1 is an aldehyde dehydrogenase 2 (ALDH2) activator [1]. Alda 1 specifically activating the ALDH2 enzyme in mitochondria, enhances the enzyme's ability to metabolize toxic aldehydes such as acetaldehyde, thereby reducing cellular damage caused by these substances [2-3]. Alda 1 is primarily used to study diseases associated with abnormal acetaldehyde metabolism [4].
In human pulmonary alveolar epithelial cells, Alda 1 (20μM; 1h) pretreatment can alleviate lung ischemia-reperfusion injury [5]. In SH-SY5Y cells, pretreatment with Alda 1 (20 μM; 24 h) restored ALDH2 activity and content, increased mitochondrial membrane potential, and reduced reactive oxygen species in cells [6].
In C57BL/6J mice, after Alda 1 (5mg/kg; ip; single injection) administration elevated hepatic ALDH activity, which was blocked by the specific ALDH2 inhibitor, daidzin [7]. In liver ischemia-reperfusion injury (IRI) mice model, Alda 1 (30mg/kg; ip; single injection) mediated ALDH2 activation may improve hepatic IRI by scavenging reactive aldehydes and enhancing autophagy [8]. In hyperoxia mice model, Alda 1 (8mg/kg; sc; 48h) pretreatment attenuates hyperoxia-induced immune cell infiltration [9].
References:
[1]. Stachowicz A, Olszanecki R, Suski M, et al. Proteomic analysis of mitochondria-enriched fraction isolated from the frontal cortex and hippocampus of apolipoprotein E knockout mice treated with Alda-1, an activator of mitochondrial aldehyde dehydrogenase (ALDH2)[J]. International Journal of Molecular Sciences, 2017, 18(2): 435.
[2]. Stachowicz A, Głombik K, Olszanecki R, et al. The impact of mitochondrial aldehyde dehydrogenase (ALDH2) activation by Alda-1 on the behavioral and biochemical disturbances in animal model of depression[J]. Brain, Behavior, and Immunity, 2016, 51: 144-153.
[3]. Ikeda T, Takahashi T, Tsujita M, et al. Effects of Alda-1, an aldehyde dehydrogenase-2 agonist, on hypoglycemic neuronal death[J]. PLoS One, 2015, 10(6): e0128844.
[4]. Stachowicz A, Olszanecki R, Suski M, et al. Mitochondrial aldehyde dehydrogenase activation by Alda‐1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E‐knockout mice[J]. Journal of the American Heart Association, 2014, 3(6): e001329.
[5]. Ding J, Zhang Q, Luo Q, et al. Alda-1 attenuates lung ischemia-reperfusion injury by reducing 4-hydroxy-2-nonenal in alveolar epithelial cells[J]. Critical care medicine, 2016, 44(7): e544-e552.
[6]. Deza-Ponzio R, Albrecht P A, Fernandez-Hubeid L E, et al. ALDH2 inhibition by lead and ethanol elicits redox imbalance and mitochondrial dysfunction in SH-SY5Y human neuroblastoma cell line: Reversion by Alda-1[J]. Neurotoxicology, 2023, 97: 12-24.
[7]. Zhong W, Zhang W, Li Q, et al. Pharmacological activation of aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic steatosis and cell death in mice[J]. Journal of hepatology, 2015, 62(6): 1375-1381.
[8]. Li M, Xu M, Li J, et al. Alda‐1 Ameliorates Liver Ischemia‐Reperfusion Injury by Activating Aldehyde Dehydrogenase 2 and Enhancing Autophagy in Mice[J]. Journal of Immunology Research, 2018, 2018(1): 9807139.
[9]. Sidramagowda Patil S, Hernández-Cuervo H, Fukumoto J, et al. Alda-1 attenuates hyperoxia-induced acute lung injury in mice[J]. Frontiers in pharmacology, 2021, 11: 597942.
Alda 1是一种醛脱氢酶2（ALDH2）激活剂 [1]。Alda 1特异性激活线粒体中的ALDH2酶，增强该酶代谢乙醛等毒性醛类物质的能力，从而减轻这些物质对细胞造成的损伤 [2-3]。Alda 1主要用于研究与乙醛代谢异常相关的疾病 [4]。
在人肺泡上皮细胞中，Alda 1（20μM；1h）预处理可减轻肺缺血-再灌注损伤 [5]。在SH-SY5Y细胞中，Alda 1（20μM；24h）预处理可恢复ALDH2活性和含量，提高线粒体膜电位，并降低细胞中的活性氧 [6]。
在C57BL/6J小鼠中，给予Alda 1（5mg/kg；ip；单次注射）后，肝脏ALDH活性升高，而该活性可被特异性ALDH2抑制剂大豆苷元阻断 [7]。在肝脏缺血-再灌注损伤（IRI）小鼠模型中，Alda 1（30mg/kg；ip；单次注射）介导的ALDH2激活可能通过清除活性醛和增强自噬来改善肝脏IRI [8]。在高氧小鼠模型中，Alda 1（8mg/kg；sc；48h）预处理可减轻高氧诱导的免疫细胞浸润 [9]。
| Cell experiment [1]: | |
Cell lines | Human pulmonary alveolar epithelial cells |
Preparation Method | Primary human pulmonary alveolar epithelial cells were cultured at 37℃ and 5% CO2, in alveolar epithelial cell medium and endothelial cell-growth medium MV2. Hypoxia was induced by exposing the cells for 24 hours to serum-deprived media in a sealed anaerobic jar fitted with an AnaeroPack to scavenge any free oxygen. The cells were then washed with PBS and were reoxygenated for 2 hours under normal conditions in complete medium. Alda 1, 20μM, was added to the medium for 1 hour before hypoxic exposure of the hypoxia/reoxygenation (H/R) + Alda 1 group. |
Reaction Conditions | 20μM; 1h |
Applications | Alda 1 pretreatment can alleviate lung ischemia-reperfusion injury. |
| Animal experiment [2]: | |
Animal models | C57BL/6J mice |
Preparation Method | Mice were given 5mg/kg body weight (BW) Alda 1 (dissolved in dimethyl sulfoxide, DMSO) at 9:00 am via three routes, intraperitoneal injection (i.p.). Livers were collected 3 hours after treatments, and hepatic ALDH activity was immediately measured. To assess the specificity of Alda 1 on activating ALDH2, mice were given an ALDH2 specific inhibitor, daidzin, at 50mg/kg BW (dissolved in DMSO) via i.p. along with 5mg/kg BW Alda 1 administration at 9:00 am (n = 4). Three hours later, liver and ileum were collected, mitochondrial and cytosolic fractions from the liver were isolated, and ALDH activity was immediately measured. |
Dosage form | 5mg/kg; ip; single injection |
Applications | One dose of Alda 1 administration elevated hepatic ALDH activity, which was blocked by the specific ALDH2 inhibitor, daidzin. |
References: | |
| Cas No. | 349438-38-6 | SDF | |
| 别名 | N-(1,3-苯并二氧杂环戊烯-5-基甲基)-2,6-二氯苯甲酰胺 | ||
| 化学名 | N-(benzo[d][1,3]dioxol-5-ylmethyl)-2,6-dichlorobenzamide | ||
| Canonical SMILES | ClC1=CC=CC(Cl)=C1C(NCC2=CC=C3OCOC3=C2)=O | ||
| 分子式 | C15H11Cl2NO3 | 分子量 | 324.16 |
| 溶解度 | ≥ 15.15mg/mL in DMSO | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 3.0849 mL | 15.4245 mL | 30.849 mL |
| 5 mM | 617 μL | 3.0849 mL | 6.1698 mL |
| 10 mM | 308.5 μL | 1.5424 mL | 3.0849 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
